Asset Details
Do you wish to reserve the book?
Early continuous blood purification affects TNF‐α, IL‐1β, and IL‐6 in patients with severe acute pancreatitis via inhibiting TLR4 signaling pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Early continuous blood purification affects TNF‐α, IL‐1β, and IL‐6 in patients with severe acute pancreatitis via inhibiting TLR4 signaling pathway
Do you wish to request the book?
Early continuous blood purification affects TNF‐α, IL‐1β, and IL‐6 in patients with severe acute pancreatitis via inhibiting TLR4 signaling pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Early continuous blood purification affects TNF‐α, IL‐1β, and IL‐6 in patients with severe acute pancreatitis via inhibiting TLR4 signaling pathway
2022
Overview
To exploit whether early continuous blood purification (CBP) inhibits the Toll‐like receptors 4 (TLR4) signaling pathway in the peripheral blood of patients with severe acute pancreatitis (SAP) and whether it affects the abundance of inflammatory factors; 130 SAP patients were randomly selected and divided into Groups B and C. Both groups received conventional treatment. Among them, Group C was given early CBP treatment. Another 60 healthy cases in physical examination at the same time were selected as Group A. The abundances of TLR4 and inflammatory factors were detected before and after treatment. Compared with Group B, (1) the symptoms in Group C improved more markedly; (2) protein contents of TLR4 and nuclear factor kappa B (NF‐κB) in Group C diminished more signally; (3) the abundances of tumor necrosis factor alpha (TNF‐α), cytokine interleukin‐1β (IL‐1β), and cytokine interleukin 6 (IL‐6) in Group C decreased (p < 0.05); and (4) the abundance of TLR4 in Group C was positively correlated with those of TNF‐α, IL‐1β, and IL‐6 after treatment (all p < 0.001). Early CBP inhibits TLR4 signaling pathway in SAP patients and attenuates the abundance of inflammatory factors to a certain extent, which may provide a new clinical treatment strategy for SAP.
Publisher
Wiley Publishing Asia Pty Ltd,John Wiley & Sons, Inc,Wiley
